{"transactions":[{"id":2085526,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121598,"kind":"person","name":"BLUTT MITCHELL J MD","position":1,"cik":"0001097955","reported_name":"BLUTT MITCHELL J MD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121599,"kind":"person","name":"Soffer Benny","position":2,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121600,"kind":"person","name":"Livingston Kevin Harold","position":3,"cik":"0001828234","reported_name":"Livingston Kevin Harold","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105397,"kind":"organization","name":"Consonance Capital Management LP","position":4,"cik":"0001544773","reported_name":"Consonance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121601,"kind":"organization","name":"Consonance Capman GP, LLC","position":5,"cik":"0001620428","reported_name":"Consonance Capman GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121602,"kind":"person","name":"Consonance Life Sciences","position":6,"cik":"0001824774","reported_name":"Consonance Life Sciences","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-12-15T09:30:50.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":144666,"ownership":{"direct":false,"nature":"By Consonance Life Sciences, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Purchase Agreement, Consonance Life Sciences agreed to sell to the Issuer 1,885,000 shares of common stock of the Issuer and warrants to purchase 144,666 shares of common stock of the Issuer for an aggregate purchase price of $942,500.  Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Pursuant to the Purchase Agreement, Consonance Life Sciences agreed to sell to the Issuer 1,885,000 shares of common stock of the Issuer and warrants to purchase 144,666 shares of common stock of the Issuer for an aggregate purchase price of $942,500.  Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Pursuant to the Purchase Agreement, Consonance Life Sciences agreed to sell to the Issuer 1,885,000 shares of common stock of the Issuer and warrants to purchase 144,666 shares of common stock of the Issuer for an aggregate purchase price of $942,500.  Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Consonance Life Sciences is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities that were held by Consonance Life Sciences except to the extent of their pecuniary interest therein.  The Master Account, Consonance Opportunity Master and the Managed Account in the aggregate own the majority of the unit interests in Consonance Life Sciences."}],"balance_after":0,"derivative":{"exercise_price":11.5,"underlying":"Common Stock","underlying_shares":144666},"source":{"system":"sec-edgar","filing":"0000899243-22-038571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1097955/000089924322038571/doc4.xml","form_type":"4"}},{"id":2085525,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121598,"kind":"person","name":"BLUTT MITCHELL J MD","position":1,"cik":"0001097955","reported_name":"BLUTT MITCHELL J MD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121599,"kind":"person","name":"Soffer Benny","position":2,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121600,"kind":"person","name":"Livingston Kevin Harold","position":3,"cik":"0001828234","reported_name":"Livingston Kevin Harold","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105397,"kind":"organization","name":"Consonance Capital Management LP","position":4,"cik":"0001544773","reported_name":"Consonance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121601,"kind":"organization","name":"Consonance Capman GP, LLC","position":5,"cik":"0001620428","reported_name":"Consonance Capman GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121602,"kind":"person","name":"Consonance Life Sciences","position":6,"cik":"0001824774","reported_name":"Consonance Life Sciences","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-12-15T09:30:50.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":150275,"ownership":{"direct":false,"nature":"By Managed Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, the Managed Account agreed to sell to the Issuer 450,827 shares of common stock of the Issuer and warrants to purchase 150,275 shares of common stock of the Issuer for an aggregate purchase price of $225,413.50. Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Pursuant to the Purchase Agreement, the Managed Account agreed to sell to the Issuer 450,827 shares of common stock of the Issuer and warrants to purchase 150,275 shares of common stock of the Issuer for an aggregate purchase price of $225,413.50. Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Pursuant to the Purchase Agreement, the Managed Account agreed to sell to the Issuer 450,827 shares of common stock of the Issuer and warrants to purchase 150,275 shares of common stock of the Issuer for an aggregate purchase price of $225,413.50. Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Consonance Management was an indirect beneficial owner of the securities reported herein that were held by the Managed Account.  Consonance Management is the investment adviser of the Managed Account and exercises voting and investment power over the securities of the Issuer held by the Managed Account.  Capman is the general partner of Consonance Management.  Consonance Management receives an asset-based fee, but has no pecuniary interest.  Mitchell Blutt is the manager and member of Capman.  Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of the securities that were held by the Managed Account except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":11.5,"underlying":"Common Stock","underlying_shares":150275},"source":{"system":"sec-edgar","filing":"0000899243-22-038571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1097955/000089924322038571/doc4.xml","form_type":"4"}},{"id":2085524,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121598,"kind":"person","name":"BLUTT MITCHELL J MD","position":1,"cik":"0001097955","reported_name":"BLUTT MITCHELL J MD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121599,"kind":"person","name":"Soffer Benny","position":2,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121600,"kind":"person","name":"Livingston Kevin Harold","position":3,"cik":"0001828234","reported_name":"Livingston Kevin Harold","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105397,"kind":"organization","name":"Consonance Capital Management LP","position":4,"cik":"0001544773","reported_name":"Consonance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121601,"kind":"organization","name":"Consonance Capman GP, LLC","position":5,"cik":"0001620428","reported_name":"Consonance Capman GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121602,"kind":"person","name":"Consonance Life Sciences","position":6,"cik":"0001824774","reported_name":"Consonance Life Sciences","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-12-15T09:30:50.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":432639,"ownership":{"direct":false,"nature":"By Consonance Capital Opportunity Master Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Purchase Agreement, Consonance Opportunity Master agreed to sell to the Issuer 1,297,922 shares of common stock of the Issuer and warrants to purchase 432,639 shares of common stock of the Issuer for an aggregate purchase price of $648,961.  Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Purchase Agreement, Consonance Opportunity Master agreed to sell to the Issuer 1,297,922 shares of common stock of the Issuer and warrants to purchase 432,639 shares of common stock of the Issuer for an aggregate purchase price of $648,961.  Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Purchase Agreement, Consonance Opportunity Master agreed to sell to the Issuer 1,297,922 shares of common stock of the Issuer and warrants to purchase 432,639 shares of common stock of the Issuer for an aggregate purchase price of $648,961.  Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Consonance Management was an indirect beneficial owner of the securities reported herein that were held by Consonance Opportunity Master.  Consonance Management is the investment adviser of Consonance Opportunity Master, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by Consonance Opportunity Master.  Capman is the general partner of Consonance Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"(Continued from Footnote 5) Consonance Management receives an asset-based fee, but has no pecuniary interest.  Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the securities held by Consonance Opportunity Master as the manager and member of the general partner of Consonance Opportunity Master and thereby is entitled to a portion of the profits allocation.  Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of the securities that were held by Consonance Opportunity Master except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":11.5,"underlying":"Common Stock","underlying_shares":432639},"source":{"system":"sec-edgar","filing":"0000899243-22-038571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1097955/000089924322038571/doc4.xml","form_type":"4"}},{"id":2085523,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121598,"kind":"person","name":"BLUTT MITCHELL J MD","position":1,"cik":"0001097955","reported_name":"BLUTT MITCHELL J MD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121599,"kind":"person","name":"Soffer Benny","position":2,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121600,"kind":"person","name":"Livingston Kevin Harold","position":3,"cik":"0001828234","reported_name":"Livingston Kevin Harold","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105397,"kind":"organization","name":"Consonance Capital Management LP","position":4,"cik":"0001544773","reported_name":"Consonance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121601,"kind":"organization","name":"Consonance Capman GP, LLC","position":5,"cik":"0001620428","reported_name":"Consonance Capman GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121602,"kind":"person","name":"Consonance Life Sciences","position":6,"cik":"0001824774","reported_name":"Consonance Life Sciences","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-12-15T09:30:50.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":582916,"ownership":{"direct":false,"nature":"By Consonance Capital Master Account LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 12, 2022, Consonance Capital Master Account LP (the \"Master Account\"), Consonance Capital Opportunity Master Fund, LP (\"Consonance Opportunity Master\"), a certain managed account (the \"Managed Account\"), Consonance Life Sciences, LLC (\"Consonance Life Sciences\"), and Surrozen, Inc. (the \"Issuer\") entered into a Securities Purchase Agreement (the \"Purchase Agreement\").  Pursuant to the Purchase Agreement, Master Account agreed to sell to the Issuer 1,748,750 shares of common stock of the Issuer and warrants to purchase 582,916 shares of common stock of the Issuer for an aggregate purchase price of $874,375. Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 12, 2022, Consonance Capital Master Account LP (the \"Master Account\"), Consonance Capital Opportunity Master Fund, LP (\"Consonance Opportunity Master\"), a certain managed account (the \"Managed Account\"), Consonance Life Sciences, LLC (\"Consonance Life Sciences\"), and Surrozen, Inc. (the \"Issuer\") entered into a Securities Purchase Agreement (the \"Purchase Agreement\").  Pursuant to the Purchase Agreement, Master Account agreed to sell to the Issuer 1,748,750 shares of common stock of the Issuer and warrants to purchase 582,916 shares of common stock of the Issuer for an aggregate purchase price of $874,375. Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 12, 2022, Consonance Capital Master Account LP (the \"Master Account\"), Consonance Capital Opportunity Master Fund, LP (\"Consonance Opportunity Master\"), a certain managed account (the \"Managed Account\"), Consonance Life Sciences, LLC (\"Consonance Life Sciences\"), and Surrozen, Inc. (the \"Issuer\") entered into a Securities Purchase Agreement (the \"Purchase Agreement\").  Pursuant to the Purchase Agreement, Master Account agreed to sell to the Issuer 1,748,750 shares of common stock of the Issuer and warrants to purchase 582,916 shares of common stock of the Issuer for an aggregate purchase price of $874,375. Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consonance Capital Management LP (\"Consonance Management\") was an indirect beneficial owner of the securities reported herein that were held by the Master Account.  Consonance Management is the investment adviser of the Master Account, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by the Master Account.  Consonance Capman GP LLC (\"Capman\") is the general partner of Consonance Management.  Consonance Management receives an asset-based fee, but has no pecuniary interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the securities held by the Master Account as the manager and member of the general partner of the Master Account and thereby is entitled to a portion of the profits allocation.  Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of the securities that were held by the Master Account except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":11.5,"underlying":"Common Stock","underlying_shares":582916},"source":{"system":"sec-edgar","filing":"0000899243-22-038571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1097955/000089924322038571/doc4.xml","form_type":"4"}},{"id":2085522,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121598,"kind":"person","name":"BLUTT MITCHELL J MD","position":1,"cik":"0001097955","reported_name":"BLUTT MITCHELL J MD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121599,"kind":"person","name":"Soffer Benny","position":2,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121600,"kind":"person","name":"Livingston Kevin Harold","position":3,"cik":"0001828234","reported_name":"Livingston Kevin Harold","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105397,"kind":"organization","name":"Consonance Capital Management LP","position":4,"cik":"0001544773","reported_name":"Consonance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121601,"kind":"organization","name":"Consonance Capman GP, LLC","position":5,"cik":"0001620428","reported_name":"Consonance Capman GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121602,"kind":"person","name":"Consonance Life Sciences","position":6,"cik":"0001824774","reported_name":"Consonance Life Sciences","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T09:30:50.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":1885000,"ownership":{"direct":false,"nature":"By Consonance Life Sciences, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Pursuant to the Purchase Agreement, Consonance Life Sciences agreed to sell to the Issuer 1,885,000 shares of common stock of the Issuer and warrants to purchase 144,666 shares of common stock of the Issuer for an aggregate purchase price of $942,500.  Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F10","text":"Consonance Life Sciences is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities that were held by Consonance Life Sciences except to the extent of their pecuniary interest therein.  The Master Account, Consonance Opportunity Master and the Managed Account in the aggregate own the majority of the unit interests in Consonance Life Sciences."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-038571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1097955/000089924322038571/doc4.xml","form_type":"4"}},{"id":2085521,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121598,"kind":"person","name":"BLUTT MITCHELL J MD","position":1,"cik":"0001097955","reported_name":"BLUTT MITCHELL J MD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121599,"kind":"person","name":"Soffer Benny","position":2,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121600,"kind":"person","name":"Livingston Kevin Harold","position":3,"cik":"0001828234","reported_name":"Livingston Kevin Harold","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105397,"kind":"organization","name":"Consonance Capital Management LP","position":4,"cik":"0001544773","reported_name":"Consonance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121601,"kind":"organization","name":"Consonance Capman GP, LLC","position":5,"cik":"0001620428","reported_name":"Consonance Capman GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121602,"kind":"person","name":"Consonance Life Sciences","position":6,"cik":"0001824774","reported_name":"Consonance Life Sciences","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T09:30:50.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":450827,"ownership":{"direct":false,"nature":"By Managed Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Purchase Agreement, the Managed Account agreed to sell to the Issuer 450,827 shares of common stock of the Issuer and warrants to purchase 150,275 shares of common stock of the Issuer for an aggregate purchase price of $225,413.50. Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Consonance Management was an indirect beneficial owner of the securities reported herein that were held by the Managed Account.  Consonance Management is the investment adviser of the Managed Account and exercises voting and investment power over the securities of the Issuer held by the Managed Account.  Capman is the general partner of Consonance Management.  Consonance Management receives an asset-based fee, but has no pecuniary interest.  Mitchell Blutt is the manager and member of Capman.  Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of the securities that were held by the Managed Account except to the extent of their pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-038571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1097955/000089924322038571/doc4.xml","form_type":"4"}},{"id":2085520,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121598,"kind":"person","name":"BLUTT MITCHELL J MD","position":1,"cik":"0001097955","reported_name":"BLUTT MITCHELL J MD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121599,"kind":"person","name":"Soffer Benny","position":2,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121600,"kind":"person","name":"Livingston Kevin Harold","position":3,"cik":"0001828234","reported_name":"Livingston Kevin Harold","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105397,"kind":"organization","name":"Consonance Capital Management LP","position":4,"cik":"0001544773","reported_name":"Consonance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121601,"kind":"organization","name":"Consonance Capman GP, LLC","position":5,"cik":"0001620428","reported_name":"Consonance Capman GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121602,"kind":"person","name":"Consonance Life Sciences","position":6,"cik":"0001824774","reported_name":"Consonance Life Sciences","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T09:30:50.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":1297922,"ownership":{"direct":false,"nature":"By Consonance Capital Opportunity Master Fund, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Purchase Agreement, Consonance Opportunity Master agreed to sell to the Issuer 1,297,922 shares of common stock of the Issuer and warrants to purchase 432,639 shares of common stock of the Issuer for an aggregate purchase price of $648,961.  Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Consonance Management was an indirect beneficial owner of the securities reported herein that were held by Consonance Opportunity Master.  Consonance Management is the investment adviser of Consonance Opportunity Master, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by Consonance Opportunity Master.  Capman is the general partner of Consonance Management."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"(Continued from Footnote 5) Consonance Management receives an asset-based fee, but has no pecuniary interest.  Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the securities held by Consonance Opportunity Master as the manager and member of the general partner of Consonance Opportunity Master and thereby is entitled to a portion of the profits allocation.  Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of the securities that were held by Consonance Opportunity Master except to the extent of their pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-038571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1097955/000089924322038571/doc4.xml","form_type":"4"}},{"id":2085519,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121598,"kind":"person","name":"BLUTT MITCHELL J MD","position":1,"cik":"0001097955","reported_name":"BLUTT MITCHELL J MD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121599,"kind":"person","name":"Soffer Benny","position":2,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121600,"kind":"person","name":"Livingston Kevin Harold","position":3,"cik":"0001828234","reported_name":"Livingston Kevin Harold","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105397,"kind":"organization","name":"Consonance Capital Management LP","position":4,"cik":"0001544773","reported_name":"Consonance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121601,"kind":"organization","name":"Consonance Capman GP, LLC","position":5,"cik":"0001620428","reported_name":"Consonance Capman GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121602,"kind":"person","name":"Consonance Life Sciences","position":6,"cik":"0001824774","reported_name":"Consonance Life Sciences","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T09:30:50.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":1748750,"ownership":{"direct":false,"nature":"By Consonance Capital Master Account LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 12, 2022, Consonance Capital Master Account LP (the \"Master Account\"), Consonance Capital Opportunity Master Fund, LP (\"Consonance Opportunity Master\"), a certain managed account (the \"Managed Account\"), Consonance Life Sciences, LLC (\"Consonance Life Sciences\"), and Surrozen, Inc. (the \"Issuer\") entered into a Securities Purchase Agreement (the \"Purchase Agreement\").  Pursuant to the Purchase Agreement, Master Account agreed to sell to the Issuer 1,748,750 shares of common stock of the Issuer and warrants to purchase 582,916 shares of common stock of the Issuer for an aggregate purchase price of $874,375. Each warrant entitles the holder thereof to purchase one share of common stock of the Issuer at a price of $11.50 per share, subject to adjustment.  The warrants are currently exercisable and will expire at the earlier of August 12, 2026, or upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Consonance Capital Management LP (\"Consonance Management\") was an indirect beneficial owner of the securities reported herein that were held by the Master Account.  Consonance Management is the investment adviser of the Master Account, and pursuant to an investment advisory agreement, Consonance Management exercises voting and investment power over the securities of the Issuer held by the Master Account.  Consonance Capman GP LLC (\"Capman\") is the general partner of Consonance Management.  Consonance Management receives an asset-based fee, but has no pecuniary interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"(Continued from Footnote 2) Mitchell Blutt is the manager and member of Capman and has a pecuniary interest in the securities held by the Master Account as the manager and member of the general partner of the Master Account and thereby is entitled to a portion of the profits allocation.  Each of Dr. Blutt, Consonance Management and Capman disclaims beneficial ownership of the securities that were held by the Master Account except to the extent of their pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-038571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1097955/000089924322038571/doc4.xml","form_type":"4"}},{"id":2603260,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Warrants","published_at":"2021-08-13T23:38:38.000Z","date":"2021-08-11","kind":"grant","acquired":false,"shares":144667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Pursuant to the Sponsor Letter Agreement entered into in connection with the Business Combination Agreement, Consonance Life Sciences LLC (\"Consonance Life Sciences\") agreed to contribute an aggregate of 759,000 Class B Ordinary Shares back to the Issuer for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents part of private placement units of the Issuer purchased by Consonance Life Sciences in a private placement transactions in connection with the Issuer's initial public offering for $10 per unit.  Each unit consisted of one Class A Share and one-third of one private placement warrant (\"Warrant\"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share.  The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering.  The Warrants will expire at 5:00 p.m., New York City time, five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents part of private placement units of the Issuer purchased by Consonance Life Sciences in a private placement transactions in connection with the Issuer's initial public offering for $10 per unit.  Each unit consisted of one Class A Share and one-third of one private placement warrant (\"Warrant\"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share.  The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering.  The Warrants will expire at 5:00 p.m., New York City time, five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held by Consonance Life Sciences. Consonance Life Sciences is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities held by Consonance Life Sciences except to the extent of their pecuniary interest therein."}],"balance_after":144667,"derivative":{"exercise_price":11.5,"underlying":"Common Stock","underlying_shares":144667},"source":{"system":"sec-edgar","filing":"0000899243-21-033039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321033039/doc4.xml","form_type":"4"}},{"id":2603259,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Warrants","published_at":"2021-08-13T23:38:38.000Z","date":"2021-08-11","kind":"disposition_to_issuer","acquired":false,"shares":144667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Pursuant to the Sponsor Letter Agreement entered into in connection with the Business Combination Agreement, Consonance Life Sciences LLC (\"Consonance Life Sciences\") agreed to contribute an aggregate of 759,000 Class B Ordinary Shares back to the Issuer for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents part of private placement units of the Issuer purchased by Consonance Life Sciences in a private placement transactions in connection with the Issuer's initial public offering for $10 per unit.  Each unit consisted of one Class A Share and one-third of one private placement warrant (\"Warrant\"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share.  The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering.  The Warrants will expire at 5:00 p.m., New York City time, five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents part of private placement units of the Issuer purchased by Consonance Life Sciences in a private placement transactions in connection with the Issuer's initial public offering for $10 per unit.  Each unit consisted of one Class A Share and one-third of one private placement warrant (\"Warrant\"), with each whole Warrant entitling the holder to purchase one Class A Share at $11.50 per share.  The Warrants will not become exercisable until the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering.  The Warrants will expire at 5:00 p.m., New York City time, five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held by Consonance Life Sciences. Consonance Life Sciences is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities held by Consonance Life Sciences except to the extent of their pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":11.5,"underlying":"Class A Ordinary Shares","underlying_shares":144667},"source":{"system":"sec-edgar","filing":"0000899243-21-033039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321033039/doc4.xml","form_type":"4"}},{"id":2603258,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Common Stock","published_at":"2021-08-13T23:38:38.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":1451000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 15, 2021, Consonance-HFW Acquisition Corp. (the \"Issuer\") entered into a Business Combination Agreement (the \"Business Combination Agreement\"), by and among the Issuer, Perseverance Merger Sub Inc. (\"Merger Sub\"), and Surrozen, Inc. (\"Surrozen\").  The Business Combination (as defined below) pursuant to the Business Combination Agreement closed on August 11, 2021.  Pursuant to the terms of the Business Combination Agreement, on the closing date: (i) the Issuer became a Delaware corporation (the \"Domestication\") and, in connection with the Domestication, (A) the Issuer's name changed to \"Surrozen, Inc.\", (B) each outstanding Class A Ordinary Share of the Issuer (\"Class A Share\") and each outstanding Class B Ordinary Share of the Issuer became one share of common stock of Issuer (the \"Common Stock\") in transactions exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), pursuant to Rule 16b-3 and Rule 16b-7 under the Exchange Act,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1), and (C) each outstanding warrant of the Issuer became one warrant to purchase one share of Common Stock; and (ii) following the Domestication, Merger Sub merged with and into Surrozen, with Surrozen as the surviving company in the merger and, after giving effect to such merger, continuing as a wholly-owned subsidiary of Issuer (the \"Merger\").  The Domestication, the Merger and the other transactions contemplated by the Business Combination Agreement are hereinafter referred to as the \"Business Combination\"."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held by Consonance Life Sciences. Consonance Life Sciences is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities held by Consonance Life Sciences except to the extent of their pecuniary interest therein."}],"balance_after":1885000,"source":{"system":"sec-edgar","filing":"0000899243-21-033039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321033039/doc4.xml","form_type":"4"}},{"id":2603257,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Common Stock","published_at":"2021-08-13T23:38:38.000Z","date":"2021-08-11","kind":"grant","acquired":true,"shares":434000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 15, 2021, Consonance-HFW Acquisition Corp. (the \"Issuer\") entered into a Business Combination Agreement (the \"Business Combination Agreement\"), by and among the Issuer, Perseverance Merger Sub Inc. (\"Merger Sub\"), and Surrozen, Inc. (\"Surrozen\").  The Business Combination (as defined below) pursuant to the Business Combination Agreement closed on August 11, 2021.  Pursuant to the terms of the Business Combination Agreement, on the closing date: (i) the Issuer became a Delaware corporation (the \"Domestication\") and, in connection with the Domestication, (A) the Issuer's name changed to \"Surrozen, Inc.\", (B) each outstanding Class A Ordinary Share of the Issuer (\"Class A Share\") and each outstanding Class B Ordinary Share of the Issuer became one share of common stock of Issuer (the \"Common Stock\") in transactions exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), pursuant to Rule 16b-3 and Rule 16b-7 under the Exchange Act,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1), and (C) each outstanding warrant of the Issuer became one warrant to purchase one share of Common Stock; and (ii) following the Domestication, Merger Sub merged with and into Surrozen, with Surrozen as the surviving company in the merger and, after giving effect to such merger, continuing as a wholly-owned subsidiary of Issuer (the \"Merger\").  The Domestication, the Merger and the other transactions contemplated by the Business Combination Agreement are hereinafter referred to as the \"Business Combination\"."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held by Consonance Life Sciences. Consonance Life Sciences is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities held by Consonance Life Sciences except to the extent of their pecuniary interest therein."}],"balance_after":434000,"source":{"system":"sec-edgar","filing":"0000899243-21-033039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321033039/doc4.xml","form_type":"4"}},{"id":2603256,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Class B Ordinary Shares","published_at":"2021-08-13T23:38:38.000Z","date":"2021-08-11","kind":"disposition_to_issuer","acquired":false,"shares":1451000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 15, 2021, Consonance-HFW Acquisition Corp. (the \"Issuer\") entered into a Business Combination Agreement (the \"Business Combination Agreement\"), by and among the Issuer, Perseverance Merger Sub Inc. (\"Merger Sub\"), and Surrozen, Inc. (\"Surrozen\").  The Business Combination (as defined below) pursuant to the Business Combination Agreement closed on August 11, 2021.  Pursuant to the terms of the Business Combination Agreement, on the closing date: (i) the Issuer became a Delaware corporation (the \"Domestication\") and, in connection with the Domestication, (A) the Issuer's name changed to \"Surrozen, Inc.\", (B) each outstanding Class A Ordinary Share of the Issuer (\"Class A Share\") and each outstanding Class B Ordinary Share of the Issuer became one share of common stock of Issuer (the \"Common Stock\") in transactions exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), pursuant to Rule 16b-3 and Rule 16b-7 under the Exchange Act,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1), and (C) each outstanding warrant of the Issuer became one warrant to purchase one share of Common Stock; and (ii) following the Domestication, Merger Sub merged with and into Surrozen, with Surrozen as the surviving company in the merger and, after giving effect to such merger, continuing as a wholly-owned subsidiary of Issuer (the \"Merger\").  The Domestication, the Merger and the other transactions contemplated by the Business Combination Agreement are hereinafter referred to as the \"Business Combination\"."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held by Consonance Life Sciences. Consonance Life Sciences is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities held by Consonance Life Sciences except to the extent of their pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-033039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321033039/doc4.xml","form_type":"4"}},{"id":2603255,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Class B Ordinary Shares","published_at":"2021-08-13T23:38:38.000Z","date":"2021-08-11","kind":"other","acquired":false,"shares":759000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Sponsor Letter Agreement entered into in connection with the Business Combination Agreement, Consonance Life Sciences LLC (\"Consonance Life Sciences\") agreed to contribute an aggregate of 759,000 Class B Ordinary Shares back to the Issuer for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held by Consonance Life Sciences. Consonance Life Sciences is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities held by Consonance Life Sciences except to the extent of their pecuniary interest therein."}],"balance_after":1451000,"source":{"system":"sec-edgar","filing":"0000899243-21-033039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321033039/doc4.xml","form_type":"4"}},{"id":2603254,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Class A Ordinary Shares","published_at":"2021-08-13T23:38:38.000Z","date":"2021-08-11","kind":"disposition_to_issuer","acquired":false,"shares":434000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 15, 2021, Consonance-HFW Acquisition Corp. (the \"Issuer\") entered into a Business Combination Agreement (the \"Business Combination Agreement\"), by and among the Issuer, Perseverance Merger Sub Inc. (\"Merger Sub\"), and Surrozen, Inc. (\"Surrozen\").  The Business Combination (as defined below) pursuant to the Business Combination Agreement closed on August 11, 2021.  Pursuant to the terms of the Business Combination Agreement, on the closing date: (i) the Issuer became a Delaware corporation (the \"Domestication\") and, in connection with the Domestication, (A) the Issuer's name changed to \"Surrozen, Inc.\", (B) each outstanding Class A Ordinary Share of the Issuer (\"Class A Share\") and each outstanding Class B Ordinary Share of the Issuer became one share of common stock of Issuer (the \"Common Stock\") in transactions exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), pursuant to Rule 16b-3 and Rule 16b-7 under the Exchange Act,"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from footnote 1), and (C) each outstanding warrant of the Issuer became one warrant to purchase one share of Common Stock; and (ii) following the Domestication, Merger Sub merged with and into Surrozen, with Surrozen as the surviving company in the merger and, after giving effect to such merger, continuing as a wholly-owned subsidiary of Issuer (the \"Merger\").  The Domestication, the Merger and the other transactions contemplated by the Business Combination Agreement are hereinafter referred to as the \"Business Combination\"."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held by Consonance Life Sciences. Consonance Life Sciences is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion over the securities held by Consonance Life Sciences and may be deemed to have shared beneficial ownership of such securities. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the securities held by Consonance Life Sciences except to the extent of their pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-033039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321033039/doc4.xml","form_type":"4"}},{"id":2704693,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2021-05-19T22:29:29.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":8000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes securities underlying the 24,000 private placement units of the Issuer purchased by Consonance Life Sciences, LLC (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement upon the exercise in full of the over-allotment option granted to the underwriters to purchase additional shares in the Issuer's initial public offering. Each unit consists of one Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at $11.50 per share."},{"field":"security","element":"securityTitle","label":"F5","text":"Includes 8,000 warrants underlying the units referred to in footnote 1."},{"field":"kind","element":"transactionCoding","label":"F6","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on December 3, 2020.  The original Form 4 had the incorrect transaction code."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Includes securities underlying the 24,000 private placement units of the Issuer purchased by Consonance Life Sciences, LLC (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement upon the exercise in full of the over-allotment option granted to the underwriters to purchase additional shares in the Issuer's initial public offering. Each unit consists of one Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at $11.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants will expire five years after the completion of the Issuer's initial business combination."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":144667,"derivative":{"exercise_price":11.5,"underlying":"Class A Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0000899243-21-019994","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321019994/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-03"}},{"id":2704692,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2021-05-19T22:29:29.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":24000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on December 3, 2020.  The original Form 4 had the incorrect transaction code."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Includes securities underlying the 24,000 private placement units of the Issuer purchased by Consonance Life Sciences, LLC (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement upon the exercise in full of the over-allotment option granted to the underwriters to purchase additional shares in the Issuer's initial public offering. Each unit consists of one Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at $11.50 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":434000,"source":{"system":"sec-edgar","filing":"0000899243-21-019994","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321019994/doc4a.xml","form_type":"4/A","original_submission_date":"2020-12-03"}},{"id":2704691,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2021-05-19T22:28:31.000Z","date":"2020-11-23","kind":"grant","acquired":true,"shares":136667,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes securities underlying the 410,000 private placement units of the Issuer purchased by Consonance Life Sciences, LLC (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at $11.50 per share."},{"field":"security","element":"securityTitle","label":"F5","text":"Includes 136,667 warrants underlying the units referred to in footnote 1."},{"field":"kind","element":"transactionCoding","label":"F6","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020.  The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Includes securities underlying the 410,000 private placement units of the Issuer purchased by Consonance Life Sciences, LLC (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at $11.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants will expire five years after the completion of the Issuer's initial business combination."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":136667,"derivative":{"exercise_price":11.5,"underlying":"Class A Ordinary Shares","underlying_shares":136667},"source":{"system":"sec-edgar","filing":"0000899243-21-019993","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321019993/doc4a.xml","form_type":"4/A","original_submission_date":"2020-11-25"}},{"id":2704690,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2021-05-19T22:28:31.000Z","date":"2020-11-23","kind":"grant","acquired":true,"shares":410000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020.  The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Includes securities underlying the 410,000 private placement units of the Issuer purchased by Consonance Life Sciences, LLC (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one Class A ordinary share at $11.50 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":410000,"source":{"system":"sec-edgar","filing":"0000899243-21-019993","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321019993/doc4a.xml","form_type":"4/A","original_submission_date":"2020-11-25"}},{"id":2704689,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2021-05-19T22:28:31.000Z","date":"2020-11-18","kind":"sale","acquired":false,"shares":30000,"price":0.0109,"value":327.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020.  The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":2210000,"source":{"system":"sec-edgar","filing":"0000899243-21-019993","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321019993/doc4a.xml","form_type":"4/A","original_submission_date":"2020-11-25"}},{"id":2704688,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2021-05-19T22:28:31.000Z","date":"2020-11-18","kind":"sale","acquired":false,"shares":30000,"price":0.0109,"value":327.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020.  The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":2240000,"source":{"system":"sec-edgar","filing":"0000899243-21-019993","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321019993/doc4a.xml","form_type":"4/A","original_submission_date":"2020-11-25"}},{"id":2704687,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2021-05-19T22:28:31.000Z","date":"2020-11-18","kind":"sale","acquired":false,"shares":30000,"price":0.0109,"value":327.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020.  The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":2270000,"source":{"system":"sec-edgar","filing":"0000899243-21-019993","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321019993/doc4a.xml","form_type":"4/A","original_submission_date":"2020-11-25"}},{"id":2704686,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2021-05-19T22:28:31.000Z","date":"2020-11-10","kind":"disposition_to_issuer","acquired":false,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020.  The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Sponsor contributed these shares back to the Issuer for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":2300000,"source":{"system":"sec-edgar","filing":"0000899243-21-019993","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321019993/doc4a.xml","form_type":"4/A","original_submission_date":"2020-11-25"}},{"id":2704685,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2021-05-19T22:28:31.000Z","date":"2020-10-08","kind":"disposition_to_issuer","acquired":false,"shares":718750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020.  The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The Sponsor contributed these shares back to the Issuer for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":2875000,"source":{"system":"sec-edgar","filing":"0000899243-21-019993","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321019993/doc4a.xml","form_type":"4/A","original_submission_date":"2020-11-25"}},{"id":2704684,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2021-05-19T22:28:31.000Z","date":"2020-09-04","kind":"grant","acquired":true,"shares":3593750,"price":0.007,"value":25156.25,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This Form 4 amendment is being filed to correct the original Form 4 filed on November 25, 2020.  The original Form 4 had the incorrect transaction code, and did not include reporting of all of the required transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion over the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":3593750,"source":{"system":"sec-edgar","filing":"0000899243-21-019993","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000089924321019993/doc4a.xml","form_type":"4/A","original_submission_date":"2020-11-25"}},{"id":2957502,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2020-12-03T11:07:09.000Z","date":"2020-12-01","kind":"purchase","acquired":true,"shares":8000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes securities underlying the 24,000 private placement units of the Issuer purchased by Consonance Life Sciences (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement upon the exercise in full of the over-allotment option granted to the underwriters to purchase additional shares in the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"security","element":"securityTitle","label":"F5","text":"Includes 8,000 warrants underlying the units referred to in footnote 1."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Includes securities underlying the 24,000 private placement units of the Issuer purchased by Consonance Life Sciences (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement upon the exercise in full of the over-allotment option granted to the underwriters to purchase additional shares in the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants will expire five years after the completion of the Issuer's initial business combination."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion of the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":144667,"derivative":{"exercise_price":11.5,"underlying":"Class A Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001104659-20-131772","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000110465920131772/a4.xml","form_type":"4"}},{"id":2957501,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2020-12-03T11:07:09.000Z","date":"2020-12-01","kind":"purchase","acquired":true,"shares":24000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Includes securities underlying the 24,000 private placement units of the Issuer purchased by Consonance Life Sciences (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement upon the exercise in full of the over-allotment option granted to the underwriters to purchase additional shares in the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion of the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":434000,"source":{"system":"sec-edgar","filing":"0001104659-20-131772","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000110465920131772/a4.xml","form_type":"4"}},{"id":2965633,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant","published_at":"2020-11-25T21:05:33.000Z","date":"2020-11-23","kind":"purchase","acquired":true,"shares":136667,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes securities underlying the 410,000 private placement units of the Issuer purchased by Consonance Life Sciences (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"security","element":"securityTitle","label":"F5","text":"Includes 136,667 warrants underlying the units referred to in footnote 1."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Includes securities underlying the 410,000 private placement units of the Issuer purchased by Consonance Life Sciences (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants will become exercisable on the later of (a) 30 days after the completion of the Issuer's initial business combination or (b) 12 months from the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The warrants will expire five years after the completion of the Issuer's initial business combination."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion of the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":136667,"derivative":{"exercise_price":11.5,"underlying":"Class A Ordinary Shares","underlying_shares":136667},"source":{"system":"sec-edgar","filing":"0001104659-20-129496","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000110465920129496/a4.xml","form_type":"4"}},{"id":2965632,"issuer":{"id":6092,"kind":"organization","name":"Surrozen, Inc./DE"},"owners":[{"id":121599,"kind":"person","name":"Soffer Benny","position":1,"cik":"0001829318","reported_name":"Soffer Benny","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2020-11-25T21:05:33.000Z","date":"2020-11-23","kind":"purchase","acquired":true,"shares":410000,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Includes securities underlying the 410,000 private placement units of the Issuer purchased by Consonance Life Sciences (the \"Sponsor\") for $10.00 per private placement unit. The private placement units were purchased in a private placement that closed simultaneously with the closing of the Issuer's initial public offering. Each unit consists of one share of Class A ordinary share and one-third of one warrant, with each whole warrant entitling the holder to purchase one share of Class A ordinary share at $11.50 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Sponsor is the record holder of the shares and warrants reported herein. The Sponsor is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston. As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston have voting and investment discretion of the shares held by the Sponsor and may be deemed to have shared beneficial ownership of the shares held by the Sponsor. Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly."}],"balance_after":410000,"source":{"system":"sec-edgar","filing":"0001104659-20-129496","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1824893/000110465920129496/a4.xml","form_type":"4"}}]}